Cancer: Drugs

Department of Health and Social Care written question – answered on 17th October 2018.

Alert me about debates like this

Photo of Tim Farron Tim Farron Liberal Democrat Spokesperson (Environment, Food and Rural Affairs)

To ask the Secretary of State for Health and Social Care, if his Department will take steps as part of the ongoing negotiations for the next Pharmaceutical Price Regulation Scheme to ensure that increasing the number of combination treatments for cancer can be considered cost-effective and made available for patients.

Photo of Steve Brine Steve Brine The Parliamentary Under-Secretary for Health and Social Care

The Government is committed to supporting the United Kingdom life sciences industry and ensuring that patients can access cost-effective innovative cancer treatments and technologies at a price the National Health Service can afford. Discussions on a branded medicines voluntary agreement for 2019 onwards are ongoing and are constructive.

Does this answer the above question?

Yes1 person thinks so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.